Kebriaei, R.; Bayer, A.S.; Lapitan, C.K.; Rybak, M.J.; Somerville, G.A.; Mishra, N.N.
Activity of the Lactate Dehydrogenase Inhibitor Oxamic Acid against the Fermentative Bacterium Streptococcus mitis/oralis: Bactericidal Effects and Prevention of Daptomycin Resistance In Vitro and in an Ex Vivo Model. Antibiotics 2022, 11, 1409.
https://doi.org/10.3390/antibiotics11101409
AMA Style
Kebriaei R, Bayer AS, Lapitan CK, Rybak MJ, Somerville GA, Mishra NN.
Activity of the Lactate Dehydrogenase Inhibitor Oxamic Acid against the Fermentative Bacterium Streptococcus mitis/oralis: Bactericidal Effects and Prevention of Daptomycin Resistance In Vitro and in an Ex Vivo Model. Antibiotics. 2022; 11(10):1409.
https://doi.org/10.3390/antibiotics11101409
Chicago/Turabian Style
Kebriaei, Razieh, Arnold S. Bayer, Christian K. Lapitan, Michael J. Rybak, Greg A. Somerville, and Nagendra N. Mishra.
2022. "Activity of the Lactate Dehydrogenase Inhibitor Oxamic Acid against the Fermentative Bacterium Streptococcus mitis/oralis: Bactericidal Effects and Prevention of Daptomycin Resistance In Vitro and in an Ex Vivo Model" Antibiotics 11, no. 10: 1409.
https://doi.org/10.3390/antibiotics11101409
APA Style
Kebriaei, R., Bayer, A. S., Lapitan, C. K., Rybak, M. J., Somerville, G. A., & Mishra, N. N.
(2022). Activity of the Lactate Dehydrogenase Inhibitor Oxamic Acid against the Fermentative Bacterium Streptococcus mitis/oralis: Bactericidal Effects and Prevention of Daptomycin Resistance In Vitro and in an Ex Vivo Model. Antibiotics, 11(10), 1409.
https://doi.org/10.3390/antibiotics11101409